Zobrazeno 1 - 10
of 59
pro vyhledávání: '"El Mouaddin, N."'
Autor:
Lee A; Quadrant Health Economics Inc, Cambridge, Ontario, Canada., Davido B; Maladies Infectieuses, Hôpital Universitaire Raymond-Poincaré, AP-HP Université Paris Saclay, Garches, France., Beck E; Health Economics and Outcomes Research, Moderna Inc, Cambridge, MA, USA., Demont C; Health Economics and Outcomes Research, Moderna France, Paris, France., Joshi K; Health Economics and Outcomes Research, Moderna Inc, Cambridge, MA, USA., Kohli M; Quadrant Health Economics Inc, Cambridge, Ontario, Canada., Maschio M; Quadrant Health Economics Inc, Cambridge, Ontario, Canada., Uhart M; Health Economics and Outcomes Research, Moderna France, Paris, France., El Mouaddin N; Health Economics and Outcomes Research, Moderna France, Paris, France.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2423474. Date of Electronic Publication: 2024 Nov 14.
Autor:
Rodrigues M; Institut Curie, département d'oncologie médicale et Inserm U830, Paris, France. Electronic address: manuel.rodrigues@curie.fr., Eberst L; Institut de cancérologie de Strasbourg Europe, Strasbourg, France; Agence nationale de sécurité du médicament, Saint Denis, France., Follana P; Centre Antoine-Lacassagne, Nice, France., Gauthier L; GSK, Rueil-Malmaison, France., Jacquemin V; GSK, Rueil-Malmaison, France., Tessier C; GSK, Rueil-Malmaison, France., El Mouaddin N; GSK, Rueil-Malmaison, France., Boudier P; Institut de cancérologie de Strasbourg Europe, Strasbourg, France; Agence nationale de sécurité du médicament, Saint Denis, France., Fiteni F; Centre hospitalier universitaire de Nîmes, Nîmes/UMR Inserm IDESP, institut Desbret d'épidémiologie et de santé publique, université de Montpellier, service d'oncologie médicale, 34090 Montpellier, France., Angeli E; Hôpital Avicenne, service d'oncologie médicale, Bobigny, France., Roche S; Centre Jean-Bernard, Le Mans, France., Delanoy N; AP-HP, institut du cancer Paris CARPEM, hôpital européen Georges-Pompidou, department of medical oncology, Paris, France., Sabatier R; Aix-Marseille université, Inserm, institut Paoli-Calmettes, department of medical oncology, Marseille, France., Flippot R; Gustave-Roussy, Paris Saclay university, department of cancer medicine, Villejuif, France., de la Motte Rouge T; Centre Eugène-Marquis, Rennes, France.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2023 Oct; Vol. 110 (10), pp. 1041-1050. Date of Electronic Publication: 2023 Aug 31.
Autor:
Rodrigues, M.J., Eberst, L., Follana, P., Brunel, V., Gauthier, L., Jacquemin, V.J., Tessier, C., El Mouaddin, N., Boudier, P., Fiteni, F., Angeli, E., Roche, S., Bonnet, I., Deldycke, C., Delanoy, N., Sabatier, R., Flippot, R., De La Motte Rouge, T.
Publikováno v:
In Annals of Oncology September 2022 33 Supplement 7:S801-S802
Autor:
Morais E; Center for Observational and Real-World Evidence, MSD, Lyon. Electronic address: edith.morais@msd.com., El Mouaddin N; ICON plc, Nanterre, France., Schuurman S; ICON plc, Stockholm, Sweden., De A; ICON plc, New York, United States.
Publikováno v:
Vaccine [Vaccine] 2021 Sep 15; Vol. 39 (39), pp. 5461-5473. Date of Electronic Publication: 2021 Aug 25.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Majed L; Market Access, MSD France, Puteaux, France. Electronic address: laureenmajed@free.fr., Bresse X; Market Access, MSD Vaccins, Lyon, France., El Mouaddin N; ICON plc, Nanterre, France., Schmidt A; ICON plc, Lyon, France., Daniels VJ; EDS Center for Observational and Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USA., Pavelyev A; HCL America, Inc., Sunnyvale, CA, USA., Levy-Bachelot L; Market Access, MSD France, Puteaux, France., Elbasha E; EDS Center for Observational and Real World Evidence (CORE), Merck & Co., Inc., Kenilworth, NJ, USA.
Publikováno v:
Vaccine [Vaccine] 2021 Jan 08; Vol. 39 (2), pp. 438-446. Date of Electronic Publication: 2020 Nov 28.
Autor:
Kind AB; Department of Gynaecology and Gynaecological Oncology, University Hospital Basel, Spitalstrasse 21, CH-4056, Basel, Switzerland., Pavelyev A; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc, Kenilworth, NJ, 07033, USA.; HCL America, Inc., Sunnyvale, CA, USA., Kothari S; Center for Observational and Real-World Evidence (CORE), Merck & Co., Inc, Kenilworth, NJ, 07033, USA., El Mouaddin N; ICON plc, 55 avenue des Champs Pierreux, 92000, Nanterre, France., Schmidt A; ICON plc, 27 rue de la Villette, 69003, Lyon, France., Morais E; Outcomes Research, MSD, 162 Avenue Jean Jaurès, 69007, Lyon, France., Guggisberg P; Market Access, MSD, Werftestrasse 4, CH-6005, Luzern, Switzerland., Lienert F; Medical Affairs, MSD, Werftestrasse 4, CH-6005, Luzern, Switzerland. florian.lienert@merck.com.
Publikováno v:
BMC public health [BMC Public Health] 2020 May 12; Vol. 20 (1), pp. 671. Date of Electronic Publication: 2020 May 12.
Publikováno v:
In Value in Health October 2018 21 Supplement 3:S228-S229
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Abdoudaim, Mariem Salma1,2 (AUTHOR) lemine1987@hotmail.fr, Mohamed Abdellahi, Mohamed Val1 (AUTHOR), Mohamed Baba, Nacer Dine3 (AUTHOR), Mboumba Bouassa, Ralph-Sydney2,4,5 (AUTHOR), Ahmed, Mohamed Lemine Cheikh Brahim1 (AUTHOR), Bélec, Laurent2,6 (AUTHOR)
Publikováno v:
Diagnostics (2075-4418). Sep2024, Vol. 14 Issue 17, p1986. 25p.